New Study Validates ATTR-QOL as Effective Measure of Patient Burden

The Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL) can effectively capture the multidimensional effect of ATTR, according to a new study published in the European Heart Journal – Quality of Care & Clinical Outcomes.